← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The University Of North Texas Health Science Center At Fort Worth
$9,675,734
Total funding
13
Grants
Funding over time
peak $5.8M · FY2008–20$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
DOD$9,675,734 · 13
By mechanism
—$9,675,734 · 13
Investigators at The University Of North Texas Health Science Center At Fort Worth
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
VISION INTEGRATING STRATEGIES IN OPHTHALMOLOGY AND NEUROCHEMISTRY (VISION)$5,567,720
· FY2010 · Department of Defense
INCREASING NIGRAL TYROSINE HYDROXYLASE EXPRESSION AS A MECHANISM OF EXERCISE-MEDIATED RECOVERY: EVALUATION IN TOXIN AND RAT PARKINSON'S DISEASE GENETIC MODELS$1,491,860
· FY2019 · Defense Health Agency
PYRUVATE-ENHANCED RESUSCITATION FOR HEMORRHAGIC SHOCK AND HINDLIMB ISCHEMIA$794,613
· FY2009 · Department of the Army
A GREEN CHEMISTRY APPROACH FOR DEVELOPING ENVIRONMENT-FRIENDLY NON-RELEASE TETHERED-ANTIFOULANT POLYMER COATINGS$448,263
· FY2008 · Department of the Navy
RETINA-TARGETED ESTROGEN PRODRUG: A NEW CONCEPT FOR RETINAL PROTECTION. NEW AWARD.$376,863
· FY2020 · Defense Health Agency
DIVERSIFYING BIOMEDICAL RESEARCHERS IN PROSTATE CANCER THROUGH ACADEMIC AFFILIATIONS BETWEEN UNTHSC AND ALABAMA STATE UNIVERSITY$273,561
· FY2016 · Department of the Army
INCREASING MINORITY BIOMEDICAL RESEARCHERS IN PROSTATE CANCER THROUGH ACADEMIC AFFILIATIONS BETWEEN UNTHSC AND HBCU$198,443
· FY2010 · Department of Defense
ASSIMILATION, ACCULTURATION AND BIOMARKERS FOR PROSTATE CANCER RISK AMONG HISPANIC MEN IN THE UNITED STATES$187,500
· FY2008 · Department of the Army
ACUTE AND SUSTAINED REDUCTION OF PLASMINOGEN ACTIVIATION IN HIGHLY INVASIVE BREAST CANCERS UTILIZING ANNEXIN A2-TARGETED COMBINATORIAL NANOPARTICLES$108,000
· FY2008 · Department of the Army
DISSECTING THE ROLE OF PROTEIN KINASE C-EPSILON IN BREAST CANCER USING THREE-DIMENSIONAL CELL CULTURE$97,200
· FY2008 · Department of the Army
UNDERSTANDING THE ROLE OF IKK-EPSILON IN BREAST CANCER$96,460
· FY2009 · Department of the Army
NOVEL GENE C17ORF37 IN PROSTATE CANCER PROGRESSION AND METASTASIS: A PROSPECTIVE BIOMARKER$44,448
· FY2009 · Department of the Army
ZOLEDRONIC ACID DECORATED CURCUMIN NANOPARTICLE: A NOVEL THERAPEUTIC APPROACH TO TARGET METASTATIC BREAST CANCER$-9,197
· FY2010 · Department of Defense